﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/revvity-to-acquire-human-cell-design-in-push-to-advance-metabolic-disease-drug-discovery-21785</loc><lastmod>2026-09-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/ai-poised-to-reshape-indian-healthcare-as-hospitals-move-beyond-pilots-bain-healthquad-report-21786</loc><lastmod>2026-09-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/astrazenecas-tozorakimab-cuts-copd-exacerbations-by-up-to-34-in-broad-phase-iii-population-21787</loc><lastmod>2026-09-11T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>